Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-25-023121

Chief Operating Officer bought 30,000 shares at $0.28 ($8,400)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longcor Jarrod Chief Operating Officer 2025-01-10 Purchase +30,000 $0.28 $8,400 83,141 D: show line 1 in the form
Open-market purchases · 30,000 sh · avg $0.28 · $8,400
Loading xslF345X05/tm259066-1_4seq1.xml…